Third, the biological function of GP73 and the molecular mechanism involved are not yet defined; therefore, additional studies are needed to understand the role of GP73 as a possible biomarker of advanced fibrosis and MASH. The gene discussed is GOLM1; the disease is metabolic dysfunction-associated steatohepatitis.